Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114844) titled 'The efficacy and complications of rifampin-combined antibiotic therapy for staphylococcal periprosthetic joint infections: A multicenter, randomized controlled trial' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Fujian Medical University
Condition:
osteoarthropathy
Intervention:
rifampicin combined with antibiotic treatment group:Rifampicin combined with antibiotic treatment
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-18
Target Sample Size: rifampicin combined with antibiotic treatment ...